Pulse Biosciences

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Movers

News

Intraday Update

Markets

Trading Ideas

AILE

ASND

CLNE

CLVT

CVNA

DELL

ELAN

HSAI

LOAR

NVDA

NYCB

PACS

PLSE

SBUX

SMCI

SMTC

SPRY

UPST

Loar Holdings Posts Upbeat Results, Joins Nvidia, Clean Energy Fuels, Penumbra And Other Big Stocks Moving Higher On Tuesday

Russell,2000,Index.magnifying,Glass,Showing,The,Words.background,Of,Banknotes,And

Analyst Color

Broad U.S. Equity ETFs

Small Cap

ETFs

EVGO

IGMS

LNTH

MORF

OUST

SOUN

The Russell 2000 index of small caps recorded its best weekly performance since October 2023, surging over 6%, driven by lower-than-expected June inflation data and potential interest rate cuts.

Russell 2000 Index Notches Strongest Week Of Year, Hits 31-Month Highs: Outlook Is &#39;Clouded By Fed&#39;s Concerns Over Labor Market,&#39; Analyst Warns

ARHS

BENF

CJET

CLDI

CLEU

DYNT

GRFS

HLVX

IDYA

INTC

IONM

JEWL

KOSS

Maxeon Solar Technologies, Ltd. - Ordinary Shares

MAXN

MYNZ

NEGG

NKLA

OPTT

PARAA

Qualigen Therapeutics, Inc. - Common Stock

QLGN

RYDE

SEDG

SHPW

SIRI

SLRN

SVMH

UXIN

VIVK

VRPX

WETH

ZAPP

Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday&#39;s Mid-Day Session

Pulse Biosciences Inc

Press Releases

Pulse Biosciences, Inc. Announces Planned Redemption of Warrants

Pulse Biosciences To Present at the 43rd Annual J.P. Morgan Healthcare Conference

Pulse Biosciences, Inc. Appoints Paul LaViolette as Chief Executive Officer

Pulse Biosciences' Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium

Pulse Biosciences Announces Late-Breaking Data from its Nanosecond PFA 360° Cardiac Catheter System First-In-Human Feasibility Study Presented at the AF Symposium

Pulse Biosciences' Nanosecond PFA Technology to Be Featured in Presentations at North American Society for Interventional Thyroidology Annual Meeting

Pulse Biosciences, Inc. Appoints Jon Skinner as Chief Financial Officer

Pulse Biosciences To Present at the TD Cowen 45th Annual Health Care Conference

Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Pulse Biosciences Schedules Fourth Quarter & Full Year 2024 Financial Results Conference Call for March 27, 2025

AXTA

AngioDynamics

Artivion

Alphatec Holdings

AtriCure

Axogen

Beta Bionics

Butterfly Network, Inc. Class A Common Stock

Butterfly Network

CeriBell

Conmed

Delcath Systems

Enovis

Paragon 28

Integra LifeSciences Holdings Corporation - Common Stock

Integra Lifesciences

iRadimed

LeMaitre Vascular

NovoCure

Orthofix Medical

Omnicell

QuidelOrtho

SI-BONE

Surmodics

Treace Medical Concepts, Inc. - Common Stock

Treace Medical Concepts

TransMedics Group

Tandem Diabetes Care, Inc. - Common Stock

Tandem Diabetes Care

Varex Imaging

Stephens & Co.

Comments

Pulse Biosciences

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga